AAAAAA
Results: 1-25/36
Authors:
Hartmann, JT
Fossa, SD
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Beyer, J
Pont, J
Fizazi, K
Hecker, H
Kanz, L
Einhorn, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors, J NAT CANC, 93(22), 2001, pp. 1733-1738
Authors:
Devouassoux-Shisheboran, M
Mauduit, C
Bouvier, R
Berger, F
Bouras, M
Droz, JP
Benahmed, M
Citation: M. Devouassoux-shisheboran et al., Expression of hMLH1 and hMSH2 and assessment of microsatellite instabilityin testicular and mediastinal germ cell tumours, MOL HUM REP, 7(12), 2001, pp. 1099-1105
Authors:
Flechon, A
Culine, S
Droz, JP
Citation: A. Flechon et al., Intensive and timely chemotherapy, the key of success in testicular cancer, CR R ONC H, 37(1), 2001, pp. 35-46
Authors:
Alexandre, J
Fizazi, K
Mahe, C
Culine, S
Droz, JP
Theodore, C
Terrier-Lacombe, MJ
Citation: J. Alexandre et al., Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse, EUR J CANC, 37(5), 2001, pp. 576-582
Authors:
Coudert, B
Anthoney, A
Fiedler, W
Droz, JP
Dieras, V
Borner, M
Smyth, JF
Morant, R
de Vries, MJ
Roelvink, M
Fumoleau, P
Citation: B. Coudert et al., Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group Report, EUR J CANC, 37(17), 2001, pp. 2194-2198
Authors:
Lagrange, JL
Ramaioli, A
Theodore, C
Terrier-Lacombe, MJ
Beckendorf, V
Biron, P
Chevreau, C
Chinet-Charrot, P
Dumont, J
Delobel-Deroide, A
D'Anjou, J
Chassagne, C
Parache, RM
Karsenty, JM
Mercier, J
Droz, JP
Citation: Jl. Lagrange et al., Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patientstreated in the French anticancer centres, ANN ONCOL, 12(9), 2001, pp. 1313-1319
Authors:
Hartmann, JT
Einhorn, L
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Schmoll, HJ
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis, J CL ONCOL, 19(6), 2001, pp. 1641-1648
Authors:
Fizazi, K
Tjulandin, S
Salvioni, R
Germa-Lluch, JR
Bouzy, J
Ragan, D
Bokemeyer, C
Gerl, A
Flechon, A
de Bono, JS
Stenning, S
Horwich, A
Pont, J
Albers, P
De Giorgi, U
Bower, M
Bulanov, A
Pizzocaro, G
Aparicio, J
Nichols, CR
Theodore, C
Hartmann, JT
Schmoll, HJ
Kaye, SB
Culine, S
Droz, JP
Mahe, C
Citation: K. Fizazi et al., Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group, J CL ONCOL, 19(10), 2001, pp. 2647-2657
Authors:
Baou, N
Bouras, M
Droz, JP
Dutrieux-Berger, N
Bouvier, R
Benahmed, M
Krantic, S
Citation: N. Baou et al., Somatostatin receptor expression profile as a potential criterion for discrimination between seminoma and non-seminoma testicular tumors, CANCER DET, 25(5), 2001, pp. 446-453
Authors:
Flechon, A
Rivoire, M
Biron, P
Droz, JP
Citation: A. Flechon et al., Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors, J UROL, 165(6), 2001, pp. 1920-1926
Authors:
Flechon, A
Droz, JP
Citation: A. Flechon et Jp. Droz, Hereditary persistence of alpha-fetoprotein in testis disease, J UROL, 165(6), 2001, pp. 2004-2004
Authors:
Fizazi, K
Amato, RJ
Beuzeboc, P
Petit, N
Bouhour, D
Thiss, A
Rebischung, C
Chevreau, C
Logothetis, CJ
Droz, JP
Citation: K. Fizazi et al., Germ cell tumors in patients infected by the human immunodeficiency virus, CANCER, 92(6), 2001, pp. 1460-1467
Authors:
Rivoire, M
Elias, D
De Cian, F
Kaemmerlen, P
Theodore, C
Droz, JP
Citation: M. Rivoire et al., Multimodality treatment of patients with liver metastases from germ cell tumors - The role of surgery, CANCER, 92(3), 2001, pp. 578-587
Authors:
Bokemeyer, C
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Schmoll, HJ
Kanz, L
Einhorn, L
Nichols, CR
Hartmann, JT
Citation: C. Bokemeyer et al., Extragonadal seminoma - An international multicenter analysis of prognostic factors and long term treatment outcome, CANCER, 91(7), 2001, pp. 1394-1401
Authors:
Flechon, A
Droz, JP
Citation: A. Flechon et Jp. Droz, Is there still indication of high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?, B CANCER, 88(9), 2001, pp. 852-857
Authors:
Hartmann, JT
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Fizazi, K
Einhorn, L
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors, J NAT CANC, 92(1), 2000, pp. 54-61
Authors:
Andre, F
Fizazi, K
Culine, S
Droz, JP
Taupin, P
Lhomme, C
Terrier-Lacombe, MJ
Theodore, C
Citation: F. Andre et al., The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients, EUR J CANC, 36(11), 2000, pp. 1389-1394
Authors:
Bachelot, T
Ray-Coquard, I
Catimel, G
Ardiet, C
Guastalla, JP
Dumortier, A
Chauvin, F
Droz, JP
Philip, T
Clavel, M
Citation: T. Bachelot et al., Multivariable analysis of prognostic factors for toxicity and survival forpatients enrolled in phase I clinical trials, ANN ONCOL, 11(2), 2000, pp. 151-156
Authors:
Culine, S
Droz, JP
Citation: S. Culine et Jp. Droz, Chemotherapy in advanced androgen-independent prostate cancer 1990-1999: Adecade of progress?, ANN ONCOL, 11(12), 2000, pp. 1523-1530
Authors:
Andre, F
Fizazi, K
Culine, S
Droz, JP
Gatineau, M
Takahashi, Y
Oudard, S
Theodore, C
Citation: F. Andre et al., Peritoneal carcinomatosis in germ-cell tumor - Relations with retroperitoneal lymph node dissection, AM J CL ONC, 23(5), 2000, pp. 460-462
Authors:
Baou, N
Bouras, M
Droz, JP
Benahmed, M
Krantic, S
Citation: N. Baou et al., Evidence for a selective loss of somatostatin receptor subtype expression in male germ cell tumors of seminoma type, CARCINOGENE, 21(4), 2000, pp. 805-810
Authors:
Culine, S
Droz, JP
Citation: S. Culine et Jp. Droz, Comparative tolerability of chemotherapy regimens for germ cell cancer, DRUG SAFETY, 22(5), 2000, pp. 373-388
Authors:
Bouras, M
Tabone, E
Bertholon, J
Sommer, P
Bouvier, R
Droz, JP
Benahmed, M
Citation: M. Bouras et al., A novel SMAD4 gene mutation in seminoma germ cell tumors, CANCER RES, 60(4), 2000, pp. 922-928
Authors:
Hartmann, JT
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Einhorn, L
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors, CANCER, 88(11), 2000, pp. 2629-2635
Authors:
Freyer, G
Rougier, P
Bugat, R
Droz, JP
Marty, M
Bleiberg, H
Mignard, D
Awad, L
Herait, P
Culine, S
Trillet-Lenoir, V
Citation: G. Freyer et al., Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure, BR J CANC, 83(4), 2000, pp. 431-437